Oncohema Key

Fig. 5.1 Tamoxifen-induced cystic hyperplasia of the endometrium Hence, in asymptomatic women, there is a poor correlation between ultrasonographically measured endometrial thickness and abnormal pathology, and screening them has not…

Hyperplasia(typical)  Simple hyperplasia without atypia  Complex hyperplasia without atypia Atypical hyperplasia  Simple atypical hyperplasia  Complex atypical hyperplasia Fig. 4.1 Endometrium – simple hyperplasia Pathophysiology Oestrogen replacement therapy has been shown…

Primary tumor (T) TNM categories FIGOa stages Surgical–pathological findings TX  Primary tumor cannot be assessed T0  No evidence of primary tumor Tisb   Carcinoma in situ (preinvasive carcinoma) T1 I…

Fig. 9.1 Anterior exenteration for a case of recurrent endometrial carcinoma treated primarily by radiation Fig. 9.2 Ileal conduit with ureteric anastomosis Fig. 9.3 Ileal conduit Fig. 9.4 Recurrence on…

Graph 1.1 Five-year relative survival trend in endometrial carcinoma based on SEER database Table 1.1 Number of cases and number of deaths per 100,000 persons by race/ethnicity: endometrial carcinoma based…

Nomenclature Topography Functional category Treatment Benign endometrial hyperplasia Diffuse Prolonged estrogen effect Hormonal therapy, symptomatic Endometrial intraepithelial neoplasia Focal progressing to diffuse Precancerous Hormonal therapy or surgery Endometrial adenocarcinoma, endometrioid…

Low risk Stage I endometrioid, grade I–II, <50 % myometrial invasion, LVSI – ve Intermediate risk Stage I endometrioid, grade I–II, > 50 % myometrial invasion, LVSI – ve High-intermediate…